bioAffinity Technologies, Inc.(BIAF)

Medical - Diagnostics & Research · San Antonio, TX

$6.05-0.14 (-2.26%)

Delayed quote: Oct 6, 2026, 3:54 PM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T19:55:54.305Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:55:54.305Z.

Quote observation: 2026-10-06T19:54:53.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,534,170
TTM operating cash flow · period ending 2026-06-30: -11,468,205

FMP input reference: b8a0cb47064437e8b9c77c3ec53eeb060705b9d611480c07f1c1fa4a72564033

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BIAF Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

BIAF Competitors' Price/OCF Ratio

BIAF

bioAffinity Technologies, Inc.

Current

Market Cap

$2.53M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NUWE

Nuwellis, Inc.

vs BIAF

Market Cap

$2.56M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SHPH

Shuttle Pharmaceuticals Holdings, Inc.

vs BIAF

Market Cap

$2.43M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCO

Onconetix, Inc.

vs BIAF

Market Cap

$2.41M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs BIAF

Market Cap

$2.42M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBRX

Moleculin Biotech, Inc.

vs BIAF

Market Cap

$2.39M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ISPC

iSpecimen Inc.

vs BIAF

Market Cap

$2.69M

Price/OCF Ratio

N/A

TTM Avg

3804.98

3Y Avg

3804.98

5Y Avg

3804.98

FBLG

FibroBiologics, Inc. Common Stock

vs BIAF

Market Cap

$2.37M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

UPC

Universe Pharmaceuticals Inc.

vs BIAF

Market Cap

$2.70M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs BIAF

Market Cap

$2.32M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
bioAffinity Technologies, Inc. (BIAF)	$2.53M	N/A	N/A	N/A	N/A
Nuwellis, Inc. (NUWE)vs ›	$2.56M	N/A	N/A	N/A	N/A
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs ›	$2.43M	N/A	N/A	N/A	N/A
Onconetix, Inc. (ONCO)vs ›	$2.41M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.42M	N/A	N/A	N/A	N/A
Moleculin Biotech, Inc. (MBRX)vs ›	$2.39M	N/A	N/A	N/A	N/A
iSpecimen Inc. (ISPC)vs ›	$2.69M	N/A	3804.98	3804.98	3804.98
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.37M	N/A	N/A	N/A	N/A
Universe Pharmaceuticals Inc. (UPC)vs ›	$2.70M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.32M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

BIAF Price/OCF Ratio Metrics

BIAF Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics